StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3056% below fair value
$0.67−0.08 (-10.19%)

Close on Nov 12, 2026Market cap $33.66MP/E –Yield –

Rapid Micro Biosystems operating margin

Operating margin is operating income as a percentage of revenue.

Rapid Micro Biosystems's operating margin for the twelve months ending Jun 30, 2026 was -141.5%. For fiscal 2025 it was -141.1%, against -178.0% the year before. The highest annual figure on record is -141.1% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-141.1%+36.9
FY2024Dec 31, 2024-178.0%+73.2
FY2023Dec 31, 2023-251.2%+117.8
FY2022Dec 31, 2022-369.0%−165.7
FY2021Dec 31, 2021-203.3%−13.3
FY2020Dec 31, 2020-190.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-153.0%+14.3
Q1 FY2026Mar 31, 2026-173.1%−11.3
Q4 FY2025Dec 31, 2025-108.2%+16.2
Q3 FY2025Sep 30, 2025-145.1%+13.2
Q2 FY2025Jun 30, 2025-167.3%+34.9
Q1 FY2025Mar 31, 2025-161.8%+92.5
Q4 FY2024Dec 31, 2024-124.5%+67.9
Q3 FY2024Sep 30, 2024-158.3%+76.8
Q2 FY2024Jun 30, 2024-202.1%+98.8
Q1 FY2024Mar 31, 2024-254.4%+41.0
Q4 FY2023Dec 31, 2023-192.3%+202.3
Q3 FY2023Sep 30, 2023-235.1%+121.2
Q2 FY2023Jun 30, 2023-301.0%+63.7
Q1 FY2023Mar 31, 2023-295.4%+65.2
Q4 FY2022Dec 31, 2022-394.6%−115.1
Q3 FY2022Sep 30, 2022-356.3%−180.6
Q2 FY2022Jun 30, 2022-364.6%−187.4
Q1 FY2022Mar 31, 2022-360.6%−166.5
Q4 FY2021Dec 31, 2021-279.5%−94.0
Q3 FY2021Sep 30, 2021-175.7%−31.3
Q2 FY2021Jun 30, 2021-177.2%+54.7
Q1 FY2021Mar 31, 2021-194.0%–
Q4 FY2020Dec 31, 2020-185.5%–
Q3 FY2020Sep 30, 2020-144.4%–
Q2 FY2020Jun 30, 2020-231.9%–

More Rapid Micro Biosystems figures

See a number that looks wrong?